MyeloMATCH Master Protocol
Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 2,000 patients (estimated)
- Sponsors
- National Cancer Institute (NCI)
- Tags
- Genetic Sequencing
- Trial Type
- Treatment
- Last Update
- 3 weeks ago
- SparkCures ID
- 1988
- NCT Identifier
- NCT05564390
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.